Pharming (PHAR) Inventory Average (2019 - 2026)
Pharming's (PHAR) quarterly Inventory Average came in at $65.0 million in Q2 2026, up 5.64% YoY from $61.5 million in Q2 2025, and little changed on a QoQ basis from $64.7 million in Q1 2026.
Pharming (PHAR) Inventory Average (2019 - 2026) Analysis & Trends
Pharming (PHAR) has 7 years of Inventory Average data on file, last reported at $65.0 million in Q2 2026.
- Quarterly Inventory Average rose 5.64% year-over-year to $65.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $65.0 million (up 5.64% YoY) and the FY2025 annual result came in at $60.3 million, up 134.46% from the prior year.
- Inventory Average held at $65.0 million in Q2 2026, from $64.7 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $66.0 million in Q4 2025 to a low of -$968747.0 in Q4 2022.
- A 5-year average of $44.3 million and a median of $55.4 million in 2023 frame the typical range for Inventory Average.
- The widest YoY moves for Inventory Average: up 69946.55% in 2022, down 107.71% in 2022.
- Tracing PHAR's Inventory Average over 5 years: stood at -$968747.0 in 2022, then surged by 2637.45% to $24.6 million in 2023, then surged by 139.92% to $59.0 million in 2024, then grew by 11.94% to $66.0 million in 2025, then decreased by 1.54% to $65.0 million in 2026.
- The last three Inventory Average figures came in at $65.0 million (Q2 2026), $64.7 million (Q1 2026), and $66.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn | 65.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.00 Mn |
| Mar 31, 2026 | 64.74 Mn |
| Dec 31, 2025 | 66.02 Mn |
| Sep 30, 2025 | 65.43 Mn |
| Jun 30, 2025 | 61.53 Mn |
| Mar 31, 2025 | 57.54 Mn |
| Dec 31, 2024 | 58.98 Mn |
| Sep 30, 2024 | 60.71 Mn |
| Jun 30, 2024 | 57.54 Mn |
| Mar 31, 2024 | 25.80 Mn |
| Dec 31, 2023 | 24.58 Mn |
| Sep 30, 2023 | 53.24 Mn |
| Jun 30, 2023 | 50.58 Mn |
| Mar 31, 2023 | 23.08 Mn |
| Dec 31, 2022 | -968,747.00 |
| Sep 30, 2022 | 16.98 Mn |
| Jun 30, 2022 | 31.77 Mn |
| Mar 31, 2022 | 14.82 Mn |
| Dec 31, 2021 | 12.56 Mn |
| Sep 30, 2021 | 24.70 Mn |